Edward van der Horst PhD @vdH_Edward
Chief Scientific Officer @senseibio. #immunotherapy #CancerResearch Tweets/comments/likes are my own. Joined March 2024-
Tweets11
-
Followers11
-
Following82
-
Likes33
We’re excited to present topline clinical data for SNS-101 from the Phase I dose escalation study at the 2024 #ASCO Annual Meeting. See you there! For additional details read the full press release: investors.senseibio.com/news-releases/…
Promote an inflammatory TME counteracting tumor cell intrinsic resistance mechanisms
Promote an inflammatory TME counteracting tumor cell intrinsic resistance mechanisms
Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers dlvr.it/T5MwQV
One of the great perks @AACR was reconnecting with old friends & colleagues & meeting new ones!#CancerResearch #ScientistReunion #AACR24
Check out our Q&A blog post, “Reaching New VISTAs,” with Chief Scientific Officer, Edward van der Horst @vdH_Edward and co-author of the recently published peer-reviewed publication in Nature Communications. senseibio.com/nature-communi…
Thomas Thisted presented & discussed data at #AACR24 showing our conditionally active CD28xVISTA bispecific antibodies induce myeloid-driven tumor-specific T-cell co-stimulation. A big shoutout to our incredible scientists @senseibio💫#Immunotherapy #CancerResearch
Excited to be in #SanDiego for the #AACR24 Always such a pleasure to reunite & catch up with Bob Schreiber and very grateful for his collaboration and friendship! #Immunotherapy #CancerResearch
Check out this study from #AACR24 opening plenary speaker @jnkath: a decentralized, privacy-preserving ML framework used to train an #AI system identifies actionable molecular changes in patients with #ColorectalCancer with routine #histopathology data nature.com/articles/s4159…
Researchers have used generative artificial intelligence to help them make completely new antibodies for the first time go.nature.com/3PFTle3
A comprehensive 5★ perspective/review on cancer as a complex, systemic disease with all the hallmarks cell.com/cell/fulltext/… @CellCellPress by @CharlesSwanton and colleagues
Noelle Covin @NoelCovin
62 Followers 5K Following
Das Subha Ranjan @DasSubhaRanjan1
168 Followers 5K Following
Tomoaki Kinjo @tkinjo8
4K Followers 5K Following Postdoc in Kuhlman lab @UNC_BCBP Computational protein design for cancer immunotherapy
Muhammad Shakeel @1Muhammad092
10K Followers 9K Following Medical Student at Shiekh Zayed University. تعليم د اسلامي نړۍ د نجات ذريعه ده.
BioValues @BioValues
7K Followers 214 Following Biotech investor. Tend to focus on contrarian names. All tweets are my opinions only.
Stock_Detective @gr8fulinvestor
71 Followers 209 Following Nothing is ever investment advice. I enjoy exploring companies and business models. Everyone has to do their own DD!
Razelle Kurzrock, MD @Dr_R_Kurzrock
7K Followers 5K Following Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
Sensei Bio @senseibio
278 Followers 185 Following Pushing the boundaries of science and imagination to discover and develop innovative medicines for patients.
Kaya van der Horst @Kaya_vdH
60 Followers 215 Following research & policy intern @actiononguns // masters student @GVAGrad
Rhea vdH @vdH_Rhea
2 Followers 593 Following Realistic optimist. Passionate about democracy / digital media literacy
Tomoaki Kinjo @tkinjo8
4K Followers 5K Following Postdoc in Kuhlman lab @UNC_BCBP Computational protein design for cancer immunotherapy
Oded Rechavi @OdedRechavi
139K Followers 1K Following Don't be fooled by the rocks that I got, I'm still Oded from the block. TED: https://t.co/rcOm9TSTf5 Huberman Lab Podcast: https://t.co/xZTNlx9nbi
Miriam Merad, MD, PhD @MiriamMerad
16K Followers 468 Following Director, Immunology Institute @SinaiImmunol @IcahnMountSinai | Harnessing the innate immune system for novel therapies against cancer & inflammatory diseases.
The Netherlands Cance.. @NKI_nl
5K Followers 1K Following The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years. Our Dutch account is @hetAVL.
Nature Rev Immunol @NatRevImmunol
68K Followers 1K Following We publish immunology reviews and highlight exciting new research papers. Tweets from the editors: Alex, Kirsty, Lucy & Yvonne.
Nature Cancer @NatureCancer
33K Followers 303 Following Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.
Jedd Wolchok @wolchokj
2K Followers 66 Following
Cell Press @CellPressNews
152K Followers 1K Following Cell Press partners with scientists across all disciplines to publish and share work that will inspire future directions in research. #ScienceThatInspires
Science Immunology @SciImmunology
60K Followers 573 Following Official twitter account for the journal Science Immunology. Also find us on Facebook: https://t.co/KRKjcvpZG1…
Immunity @ImmunityCP
65K Followers 338 Following Cutting-edge research in immunology from around the world, and commentaries by thought leaders. Cell Press. Tweets by Immunity editors.
Razelle Kurzrock, MD @Dr_R_Kurzrock
7K Followers 5K Following Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
NatureRevClinOncol @NatRevClinOncol
40K Followers 250 Following The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.
Nature Immunology @NatImmunol
71K Followers 176 Following Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology.
JCellBiol @JCellBiol
48K Followers 983 Following The Journal of Cell Biology publishes peer-reviewed research on all aspects of cellular structure and function. Est. 1955 - @RockUPress
WUSM Pathology & Immu.. @wusm_pathology
4K Followers 2K Following Department of Pathology & Immunology at Washington University School of Medicine
genOway @genOway_SA
672 Followers 527 Following 20 years of expertise in the design of preclinical models of high physiological relevancy. A catalog of 30 translational models for immuno-oncology/therapies.
Cell Reports @CellReports
122K Followers 141 Following Cell Reports is an open-access journal at Cell Press, publishing weekly. Tweets by Cell Reports editors.
Nature Medicine @NatureMedicine
336K Followers 246 Following Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.
Cell @CellCellPress
246K Followers 634 Following Cell aims to publish the most exciting and provocative research in biology. Posts by Scientific Editors on the Cell Editorial team.
NEJM @NEJM
942K Followers 435 Following The New England Journal of Medicine is the world’s leading medical journal and website.
Eric Topol @EricTopol
694K Followers 589 Following physician-scientist, author, editor. Ground Truths: https://t.co/YhatcBT0hA
Pharmafocus @Pharmafocus
49K Followers 2K Following Monthly pharmaceutical, biotech & healthcare news publication for the UK, Europe and worldwide. Site updated daily with latest #pharma, #biotech & #health news.
AstraZeneca @AstraZeneca
303K Followers 2K Following We're transforming the future of healthcare by unlocking the power of what science can do. Community Guidelines: https://t.co/Kh08zUdFpT
Jason Luke, MD, FACP @jasonlukemd
6K Followers 563 Following Immunotherapy of Cancer • Melanoma • Phase I Clinical Trials • Lab: @ImmunoTiil • Disclosures: https://t.co/p3vwd3bi9o
Padmanee (Pam) Sharma.. @PamSharmaMDPhD
7K Followers 227 Following Immunologist. Oncologist. Mom. Wife to @JimAllisonPhD. Founder @TentAbrahams. Professor @MDAndersonNews.
Pfizer Inc. @pfizer
490K Followers 2K Following Breakthroughs that change patients' lives. Visit https://t.co/zipcKiG1jD to learn more. https://t.co/FPP9fmzZh6
Johnson & Johnson @JNJNews
250K Followers 2K Following Follow us to see how we're solving the world's toughest health challenges. Community Guidelines: https://t.co/XOPIzkbgzo
Novartis @Novartis
300K Followers 529 Following An innovative medicines company working to reimagine medicine. See our community guidelines: https://t.co/PnsiaxwOuy
Cantley Lab @CantleyLab
5K Followers 483 Following The Cantley Lab @harvardmed @DanaFarber. Cell Signaling | Kinases | PI3K | Cancer Metabolism. Account managed by @Tomer_M_Yaron. Tweets by Dr. Cantley signed LC
Patrick Hsu @pdhsu
30K Followers 3K Following co-founder @ArcInstitute, @BerkeleyBioE professor | researcher & investor in genome editing, biotech, AI | 🇨🇦 @harvard @broadinstitute @editasmed, Fast Grants
Vishva Dixit @dixitvishva
3K Followers 74 Following Vishva Dixit has made many contributions to biomedicine and his early work on apoptosis is prominent in introductory textbooks of Biology.
Katalin Kariko @kkariko
70K Followers 262 Following I am a scientist, working on the therapeutic use of in vitro transcribed mRNA.
Ivan Đikić @iDikic2
9K Followers 1K Following Scientist @goetheuni, Professor @IBC2_GU, Fellow @MPIBP. Interests in research, education, science popularisation & snowboarding🙃
ESMO - Eur. Oncology @myESMO
75K Followers 874 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
PEGS Summit @PEGSboston
1K Followers 630 Following PEGS - The Essential Protein & Antibody Engineering Summit organized by @chi_healthtech
Parker Institute for .. @parkerici
11K Followers 683 Following Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases
Kaya van der Horst @Kaya_vdH
60 Followers 215 Following research & policy intern @actiononguns // masters student @GVAGrad
Rhea vdH @vdH_Rhea
2 Followers 593 Following Realistic optimist. Passionate about democracy / digital media literacy
Albert Bourla @AlbertBourla
63K Followers 157 Following Chairman and CEO of @Pfizer. Father. 🇬🇷🇺🇸 Working every day for breakthroughs that change patients’ lives.
Max Planck Institute .. @MPI_Biochem
9K Followers 414 Following We tweet about our scientists, science and related topics #biochemistry #biophysics #cellbiology #structuralbiology #machinelearning https://t.co/WXiPehYTw8
Nature Reviews Cancer @NatureRevCancer
70K Followers 1K Following Nature Reviews Cancer is a monthly review journal for all researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
The Oncologist @OncJournal
23K Followers 344 Following The Oncologist Journal focuses on medical and practice issues of busy oncology, hematology and radiation professionals to aid in better cancer patient care.
Cancer Research Insti.. @CancerResearch
31K Followers 5K Following Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer #immunotherapy research.
Annals of Oncology @Annals_Oncology
47K Followers 521 Following Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
JNCI @JNCI_Now
25K Followers 3K Following Journal of the National Cancer Institute (JNCI) & JNCI Cancer Spectrum publish peer-reviewed #research on #cancer and #oncology. @OUPAcademic journals.
OncLive.com @OncLive
44K Followers 2K Following Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
The Cancer Letter @TheCancerLetter
26K Followers 2K Following The leading independent source for information on the issues that shape #oncology since 1973. Editor: @PaulBGoldberg | Historical initiative: @cancerhistproj
Cancer Cell @Cancer_Cell
65K Followers 273 Following Cancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.We’re excited to present topline clinical data for SNS-101 from the Phase I dose escalation study at the 2024 #ASCO Annual Meeting. See you there! For additional details read the full press release: investors.senseibio.com/news-releases/…
urging them to find political solutions to current conflicts that uplift all communities & ensure sustained peace. I called for increased science's funding and imagined the extraordinary discoveries we could achieve if the budget for science was only half that of the military’s.
Walking around campus @UCBerkeley with @JimAllisonPhD 💕 Reminiscing about great science that led to the field of immune checkpoint therapy!
Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers dlvr.it/T5MwQV
Congratulations to Michel Sadelain, MD, PhD, FAACR, of @MSKCancerCenter, awarded the @GairdnerAwards International Awards today for his work on CD19-CAR T cell therapy for cancer, along with Zelig Eshhar, PhD, @WeizmannScience. #AACRFellows
🚨Fantastic pair of papers in @Nature today from @EvanWeberPhD, @MackallLab and the Darcy lab @PeterMacCC on enforcing stem-like molecular programs in therapeutic T cells through overexpression of #FOXO1! 👇 nature.com/articles/s4158…. @ChildrensPhila @StanfordCancer @parkerici
Check out our Q&A blog post, “Reaching New VISTAs,” with Chief Scientific Officer, Edward van der Horst @vdH_Edward and co-author of the recently published peer-reviewed publication in Nature Communications. senseibio.com/nature-communi…
It's a picture-perfect night at Petco Park. Immediate AACR Past President Phil Greenberg kicked off at Cancer Research Night at the Padres. #AACR24
Out in @Nature concurrent with #AACR24 Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer @KenOliveLab @BenStanger01 @derlabunc nature.com/articles/s4158… nature.com/articles/s4158…
Congrats to @montypal et al. for a groundbreaking advance in ccRCC treatment! Phase I trial shows no dose-limiting toxicity, with disease control in 81% of patients & one achieving a 3-year complete response. ⭕️CAR T-cell therapy continues to show promise in solid tumors.…
Just published with the #AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell #Carcinoma, by @montypal et al. bit.ly/3J5jzTH @cityofhope @AACR
Wonderful opening plenary session @AACR with brilliant talk by @CarolynBertozzi & many collaborations discussed with @DrLizJaffee @cncurtis @Johanna_A_Joyce @AttardiLaura @snbhatia @dana_peer #womeninscience #AACR24
Register today for #CICON24, presented by CRI and @ENCI_network, in conjunction with ENCI partner organizations, @C_IMT, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held September 8-11, 2024, in National Harbor, MD: bit.ly/49Bceq8 #CancerResearch #CICON
Very excited to celebrate @AACR fellows with close friends and colleagues @PamSharmaMDPhD @JimAllisonPhD SangeetaBhatia @MIT, @ Tak Mak, @wolchokj , @BhardwajLab @ Robert Schreiber and many more
Extraordinary work that hopefully will translate into clinical applications! Thanks @CharlesSwanton for sharing in this Tweetorial.
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in @CD_AACR today rb.gy/q484j9 Tweetorial👇
Check out this study from #AACR24 opening plenary speaker @jnkath: a decentralized, privacy-preserving ML framework used to train an #AI system identifies actionable molecular changes in patients with #ColorectalCancer with routine #histopathology data nature.com/articles/s4159…
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations @CD_AACR @OncBrothers @OncoAlert @oncodaily @AACRPres @CCR_AACR #oncology #Cancer #AACR24 #AACR2024 @TaliLev123 @ElizSMcKenna aacrjournals.org/cancerdiscover…
Spatially Segregated Macrophage Populations Predict Distinct Outcomes In Colon Cancer @CD_AACR @AACR @OncoAlert @oncodaily @SciLife_ @InnovOncology #MedEd #MedX #Oncology #AACR2024 #AACR24 doi.org/10.1158/2159-8…
Trends for United States
You might like
